Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06KFR
|
||||
Former ID |
DIB003528
|
||||
Drug Name |
RP-73163
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Arteriosclerosis [ICD9: 440; ICD10:I70] | Terminated | [1] | ||
Company |
Rhone-Poulenc SA
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C26H30N4OS
|
||||
Canonical SMILES |
c1(nc(c([nH]1)c1ccccc1)c1ccccc1)[S@@](=O)CCCCCn1nc(cc1C<br />)C
|
||||
CAS Number |
CAS 154461-48-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Liver carboxylesterase | Target Info | Modulator | [2] | |
KEGG Pathway | Drug metabolism - other enzymes | ||||
Metabolic pathways | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
WikiPathways | NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | |||||
Heroin metabolism | |||||
Irinotecan Pathway | |||||
Fluoropyrimidine Activity | |||||
Phase I biotransformations, non P450 | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003588) | ||||
REF 2 | Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol. Biochem Pharmacol. 1996 Oct 25;52(8):1177-86. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.